Physician profile
Patrick Michael Mackey
NPI 1316151848
$423.71
in general payments reported to CMS, 2019-2025
8 companies · $97.79 in 2025
The $97.79 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $59.59 · 2023: $236 · 2024: $30.66 · 2025: $97.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $117.64 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $101.44 | 2022-2025 | |
| Glaxosmithkline, LLC. | $69.51 | 2022-2023 | Bexsero, Shingrix |
| Novo Nordisk INC | $64.77 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Renalytix Ai, INC. | $21.69 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Amgen INC. | $18.00 | 2023 | Repatha |
| Currax Pharmaceuticals LLC | $15.66 | 2024 | Onzetra Xsail, Contrave |
| Merck Sharp & Dohme LLC | $15.00 | 2024 | Gardasil, Capvaxive, Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mackey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.